Get complete Patent Opposition Report for Csl Behring

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Csl Behring against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3116527Method For Preparing Human Plasma ProteinsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESMay 27, 2020
EP2968434C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencySHIRE VIROPHARMAMar 28, 2018
EP1974014Oligopeptide-Free Cell Culture MediaBAXALTAJan 18, 2018

Explore Csl Behring's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3728287Apr 10, 2024Protein Purification And Virus Inactivation With Alkyl Glycosides1
EP3794013Feb 21, 2024Method And System Of Protein Extraction1
EP3564267Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity2
EP3226895Jul 22, 2020Pharmaceutical Product With Increased Stability Comprising Immunoglobulins1
EP3383894May 6, 2020Improved Media For The Expression Of Recombinant Vitamin K-Dependent Proteins2
EP2538975Sep 18, 2019Immunoglobulin Preparation And Storage System For An Immunoglobulin Preparation1
EP3006462Apr 10, 2019Method For Purification Of Alpha-1-Antitrypsin1
EP2256135Mar 13, 2019Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor1
EP2531218Dec 12, 2018Immunoglobulin Preparation1